Beta-lactamyl vasopressin Vlaantagonists

Details for Australian Patent Application No. 2002342045 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 60/329,054 12.10.01 US

3 July 2003 Application Open to Public Inspection

Published as AU-B-2002342045

4 May 2006 Change of Name(s) of Applicant(s), Section 104

Azevan Pharmaceuticals, Inc The name of the applicant has been changed to SERENIX PHARMACEUTICALS, LLC 2003

11 May 2006 Assignment before Grant

Serenix Pharmaceuticals, LLC The application has been assigned to Azevan Pharmaceuticals, Inc

19 February 2009 Application Accepted

Published as AU-B-2002342045

9 April 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 16 Feb 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

21 May 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 29 Apr 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

30 July 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 16 Feb 2009

17 September 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 29 Apr 2009

17 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.